Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study
Journal of Gastroenterology · 2026
DOI: 10.1007/s00535-026-02406-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Feng Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 1…. Hauptthemen laut MEDLINE: Phenylurea Compounds, Quinolines, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Guangzhou Basic and Applied Basic Research Foundation, Guangdong Provincial Applied Science and Technology Research and Development Program.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 106 Zhongshan Second Road, Guangzhou, 510080, China.
- Department of Cancer Center and Department of Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Second Road, Guangzhou, 510080, China.
- Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Liver Diseases and Interventional Radiology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
- Department of Liver Diseases and Interventional Radiology, Digestive Diseases Hospital, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China.
- Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Förderung
- the National Natural Science Foundation of China
- Guangzhou Basic and Applied Basic Research Foundation
- Guangdong Provincial Applied Science and Technology Research and Development Program
Zitieren
APA
Shi, F., Peng, Z., Lian, S., Mai, Q., Xia, D., Li, Q., Wang, M., Chen, S., Mei, J., Han, G., Chen, S., Kuang, M., & Chen, X. (2026). Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02406-4
Vancouver
Shi F, Peng Z, Lian S, Mai Q, Xia D, Li Q, et al. Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02406-4
BibTeX
@article{Shi2026,
author = {Shi, Feng and Peng, Zhenwei and Lian, Shanshan and Mai, Qicong and Xia, Dongdong and Li, Qi and Wang, Meng and Chen, Song and Mei, Jie and Han, Guohong and Chen, Shuting and Kuang, Ming and Chen, Xiaoming},
title = {Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02406-4}
}
EUVIMED